Buprenorphine for Opioid Use Disorder

The United States is in the midst of an epidemic of opioid overdoses and overdose deaths. Multiple factors have contributed to this epidemic. “One aspect of managing this crisis is to increase the number of providers able to treat opioid use disorder with Medication for Addiction Treatment (or MAT).”

This presentation will focus on the use of buprenorphine to treat opioid use disorder. The purpose of the program is to educate potential buprenorphine prescribers to encourage them to treat patients with opioid use disorder with buprenorphine.

This program will include a review of the opioid epidemic in the United States as well as an overview of opioid use disorder and its treatment. Information on the pharmacology and administration of buprenorphine will be presented, along with information on the clinical use of buprenorphine.  The presentation will also cover the use of buprenorphine in special populations, such as pregnant women, people with pain, and others as well as case discussions.

1. Review the pharmacology of buprenorphine in opioid use disorder
2. Describe the induction of buprenorphine for treatment of opioid use disorder
3. Identify considerations for the use of buprenorphine in special populations

This program contains a pre-test, video presentation, educational material, post-test, and a program evaluation. Credit will be awarded upon successful completion of the post-test activity with a score of 70% or better.

Sharon Stancliff, MD

Public Health Physician

AIDS Institute

New York State Department of Health

Paul Updike, MD

Medical Director of Chemical Dependency Services

Catholic Health System of Buffalo

There is no fee associated with this program for prescribers.

Support for this educational activity was made possible (in part) by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Prescribers:

ACCREDITATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

CERTIFICATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this internet enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Firefox
• Chrome

How to Enable Cookies:

• Firefox
• Chrome

Please do not use Internet Explorer as your browser for this program.

Please email pharmacyce@buffalo.edu